CN1555863A - Chinese medicine for treating keloid - Google Patents
Chinese medicine for treating keloid Download PDFInfo
- Publication number
- CN1555863A CN1555863A CNA2004100138732A CN200410013873A CN1555863A CN 1555863 A CN1555863 A CN 1555863A CN A2004100138732 A CNA2004100138732 A CN A2004100138732A CN 200410013873 A CN200410013873 A CN 200410013873A CN 1555863 A CN1555863 A CN 1555863A
- Authority
- CN
- China
- Prior art keywords
- grams
- rhizoma
- radix
- keloid
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating keloid is prepared from 14 Chinese-medicinal materials including saffron, Dragon's blood, pangolin scales, astragalus root, etc. Its advantages are regulating immunity, high curative effect, quickly taking its effect, no toxic by-effect and no recurrence.
Description
Affiliated technical field
The present invention relates to a kind of Chinese medicine for the treatment of keloid.
Background technology
Keloid is that people's human body is because congenital factors or be subjected to wound such as golden cutter is hindered, the impaired cicatrix that stays at skin surface of local organization behind the burn due to hot liquid or fire, insect and mosquito biting.Doctor trained in Western medicine it is generally acknowledged that keloid is the reaction of people's human body to inflammation, is because due to the hypertrophy of the appearance of synthetic and uneven, the unusual mucopolysaccharide of degraded of human body collagen and myofibroblast, and is relevant with people's body constitution and immunity etc.Doctor trained in Western medicine is a lot of to this type of treatment of diseases method at present, mainly contain medicine chemotherapy, compression therapy, laser therapy, cryotherapy and medicine injection treatment etc., but the prognosis effect of above-mentioned therapy is all not satisfactory, have pigmentation after the treatment to some extent or take off mistake, what have also can produce recurrence, regenerated situation.The traditional Chinese medical science then think keloid be since in the human body residual poison feel the exopathogen invasion again not to the greatest extent, due to the damp and hot knot of fighting, coagulation of QI-blood, two kinds of exceptionally sick external treatment of its Therapeutic Method and outer sick treatment by oral administration of medicines, the effect of sick treatment by oral administration of medicines is good especially in addition.In China's traditional Chinese medical science treasure-house, many prescriptions are arranged, different cicatrix diseases all there is certain curative effect, as Chinese patent disclosed " treating keloidal the Chinese herbal and crude drugs preparations " (patent No.: 00109868.3) be exactly a kind of prescription of outer preferably sick treatment by oral administration of medicines, but these numerous prescriptions are in toxic and side effects with prevent that aspect such as recurrence from still having certain defective.
Summary of the invention
For fully excavating China's traditional Chinese medical science medical treasure-house, further improve the effect of Chinese traditional treatment keloid, the present invention is according to theory of Chinese medical science, regulate on the whole and improve function of human body and immunologic function is set out, by exploring for many years, disclose a kind of easy to use, therapeutic effect good, the Chinese prescription that is difficult for recurrence and has no side effect, the technical solution adopted for the present invention to solve the technical problems is:
1, the present invention is the preparation of being made by the Chinese herbal medicine of following consumption proportion:
Stigma Croci 8~12 grams, Sanguis Draxonis 5~10 grams, Squama Manis 7~10 grams, rhizoma sparganic 7~10 grams, Rhizoma Curcumae 7~10 grams, Spica Prunellae 10~50 grams, Carapax Trionycis 20~40 grams, the Radix Astragali 20~40 grams, the Rhizoma Atractylodis Macrocephalae 10~18 grams, Rhizoma Cyperi 7~12 grams, Radix Scrophulariae 10~20 grams, Cortex Dictamni 10~15 grams, Radix Saposhnikoviae 7~12 grams, Massa Medicata Fermentata 10~20 grams.
2, preferred version of the present invention is the oral administration pills of being made by the Chinese herbal medicine of following consumption proportion:
Stigma Croci 9 grams, Sanguis Draxonis 6 grams, Squama Manis 9 grams, rhizoma sparganic 9 grams, Rhizoma Curcumae 9 grams, Spica Prunellae 30 grams, Carapax Trionycis 30 grams, the Radix Astragali 30 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Rhizoma Cyperi 9 grams, Radix Scrophulariae 15 grams, Cortex Dictamni 12 grams, Radix Saposhnikoviae 9 grams, Massa Medicata Fermentata 15 grams.
It is monarch drug that the present invention selects Stigma Croci for use, Stigma Croci Flos Carthami just by name, have another name called red blue flower, thorn Flos Carthami, Flos Carthami, it is the flower of feverfew Flos Carthami, containing Carthamus yellow is saffloside, and nature and flavor suffering, temperature have removing blood stasis, promoting the circulation of blood and blood, the effect of accent blood, be the key medicine of promoting the circulation of blood, can be used for treating that amenorrhea, difficult labour, stillborn fetus, lump in the abdomen, carbuncle are had a pain, injury from falling down etc.
Selecting and purchasing of the present invention is a ministerial drug with rhizoma sparganic, Rhizoma Curcumae, Squama Manis and Sanguis Draxonis, and wherein, rhizoma sparganic is the tuber of Sparganiaceae plant rhizoma scirpi or little rhizoma scirpi, spire rhizoma scirpi, contains volatile oil, and nature and flavor toil, flat has removing blood stasis, circulation of qi promoting, removing food stagnancy, analgesic effect; Rhizoma Curcumae is a zingiberaceous plant Rhizoma Curcumae rhizome, contains volatile oil, and main component is a sesquiterpene in the oil, and nature and flavor toil, temperature have removing blood stasis, circulation of qi promoting, removing food stagnancy, analgesic effect; Squama Manis is the scute of Manidae animal Manitis, and nature and flavor are salty, cool, having detumescence burst carbuncle, search that wind is active, the stimulating milk secretion of stimulating the menstrual flow function; Sanguis Draxonis is the resin in babassu Sanguis Draxonis fruit and the trunk, and property sweet-salty, flat has antifungal, diffusing silt analgesic therapy, hemostasia and promoting granulation function.
It is adjuvant drug that the present invention adopts the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Cyperi, Cortex Dictamni, Radix Saposhnikoviae, Radix Scrophulariae, Massa Medicata Fermentata, wherein, the Radix Astragali is the dry root of leguminous plant Radix Astragali or Inner Mongol Radix Astragali etc., sweet, the tepor of nature and flavor has benefit and defends consolidating superficial resistance, inducing diuresis to remove edema, invigorating the spleen and replenishing QI effect, the outstanding kind YIN-fire of rushing down, expelling pathogenic factors from muscles heat, hemopoietic, granulation promoting, strong taste; The Rhizoma Atractylodis Macrocephalae is a feverfew Rhizoma Atractylodis Macrocephalae rhizome, contains volatile oil, and main component is atractylol, atractylone etc. and vitamin A, and property bitter but sweet flavor, temperature have spleen reinforcing, stomach reinforcing, dampness and middle function; Rhizoma Cyperi is a sedge dried tuber rhizome, and the hot little hardship of nature and flavor is sweet, flat, has the resolving depression of regulating the flow of vital energy, pain relieving regulating menoxenia, cures mainly diseases such as incoordination between the liver and stomach, depression of QI, phlegm retention feeling of fullness; Cortex Dictamni is the root bark of rutaceae shaggy-fruited dittany, contains dictamine, shaggy-fruited dittany lactone etc., and the nature and flavor hardship is salty, cold, have dispel the wind, dampness, heat clearing away, Detoxication, cure mainly the wind heat sore, scabies, itchy skin eruption, rheumatism splenalgia, jaundice; Radix Saposhnikoviae is the root of umbelliferae Saposhnikovia divaricata, contains volatile oil, mannitol, bitterness glycosides etc., and property acrid-sweet flavor, temperature have and deliver, dispel the wind, win wet, pain relieving function; Radix Scrophulariae is the root of goatweed Radix Scrophulariae, contains alkaloid, saccharide, aminoacid, fatty acid, volatile oil, carotene etc., and the nature and flavor hardship is salty, cool, has YIN nourishing, pathogenic fire reducing, relieving restlessness, Detoxication; Massa Medicata Fermentata is that through the herbal leaven that fermentation forms, its composition had volatile oil, glycoside, fatty oil, vitamin B etc., has invigorating the spleen and regulating the stomach, effect in the accent that helps digestion after medicines such as Herba polygoni hydropiperis, Herba Artemisiae Annuae, Semen Armeniacae Amarum added flour or wheat bran mixing.
The messenger drug that the present invention adopts is a Radix Glycyrrhizae, and Radix Glycyrrhizae is the root or the root stock of glycyrrhizic legume, and nature and flavor are sweet flat, have and middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription effect;
The obtained beneficial effect of the present invention is:
1, the present invention is according to theory of Chinese medical science, regulate on the whole and improve function of human body and immunologic function is set out, the silt of prescription blood circulation promoting regulates qi, removing dampness and detoxicating mass-dissipating efficacy are remarkable, help improving body tissue's circulation after taking, reduce pigementation, make softening rapidly absorption of keloid cure short treating period, instant effect, more the back is difficult for recurrence;
2, prescription eliminating pathogenic factor for supporting vital QI of the present invention develops simultaneously, and treating both the principal and secondary aspects of a disease is suitable for the treatment of the keloid that a variety of causes causes, and has no adverse reaction and toxic and side effects.
3, formulation preparation of the present invention is simple, taking convenience.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
Embodiment
Selected medical material is cleaned respectively, dried, clay into power, cross 120 mesh sieves, by behind the following consumption proportion mix homogeneously, adopt Chinese medicine watered pill processing technology to make oral administration pills, it is standby to bottle:
Stigma Croci 9 grams, Sanguis Draxonis 6 grams, Squama Manis 9 grams, rhizoma sparganic 9 grams, Rhizoma Curcumae 9 grams, Spica Prunellae 30 grams, Carapax Trionycis 30 grams, the Radix Astragali 30 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Rhizoma Cyperi 9 grams, Radix Scrophulariae 15 grams, Cortex Dictamni 12 grams, Radix Saposhnikoviae 9 grams, Massa Medicata Fermentata 15 grams.
Using method of the present invention is as follows: take 1~10 gram pill according to the patient age and the state of an illness, every day 3 times, oral one month is a course of treatment at every turn, and stimulation food avoids pungent food during medication.
Clinical treatment 673 routine patients with screening are example, male patient's 284 examples wherein, female patient 389 examples, maximum 62 years old age of patient, minimum 3 years old, average 21 years old.Patient's keloid area maximum be 403 square centimeters, minimum 1 square centimeter, height does not wait for 0.2-1.6 centimetre.Other disease of surplus nothing.Above-mentioned patient by age reach the state of an illness use pill 1-10 gram of the present invention/time, 3 times/day, three courses of treatment of continuous oral, carry out observation of curative effect.After the treatment, 602 routine patients fully recover and follow up a case by regular visits to after 1 year and there is no the recidivist, and 64 examples take a turn for the better, invalid 7 examples, and total effective rate reaches 99%, and cure rate reaches 89.%.
Claims (2)
1, a kind of Chinese medicine for the treatment of keloid is characterized in that: the preparation that it is made by the Chinese herbal medicine of following consumption proportion:
Stigma Croci 8~12 grams, Sanguis Draxonis 5~10 grams, Squama Manis 7~10 grams, rhizoma sparganic 7~10 grams, Rhizoma Curcumae 7~10 grams, Spica Prunellae 10~50 grams, Carapax Trionycis 20~40 grams, the Radix Astragali 20~40 grams, the Rhizoma Atractylodis Macrocephalae 10~18 grams, Rhizoma Cyperi 7~12 grams, Radix Scrophulariae 10~20 grams, Cortex Dictamni 10~15 grams, Radix Saposhnikoviae 7~12 grams, Massa Medicata Fermentata 10~20 grams.
2, according to the Chinese medicine of the described treatment keloid of claim 1, it is characterized in that: the oral administration pills that it is made by the Chinese herbal medicine of following consumption proportion:
Stigma Croci 9 grams, Sanguis Draxonis 6 grams, Squama Manis 9 grams, rhizoma sparganic 9 grams, Rhizoma Curcumae 9 grams, Spica Prunellae 30 grams, Carapax Trionycis 30 grams, the Radix Astragali 30 grams, the Rhizoma Atractylodis Macrocephalae 12 grams, Rhizoma Cyperi 9 grams, Radix Scrophulariae 15 grams, Cortex Dictamni 12 grams, Radix Saposhnikoviae 9 grams, Massa Medicata Fermentata 15 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410013873 CN1224416C (en) | 2004-01-07 | 2004-01-07 | Chinese medicine for treating keloid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410013873 CN1224416C (en) | 2004-01-07 | 2004-01-07 | Chinese medicine for treating keloid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1555863A true CN1555863A (en) | 2004-12-22 |
CN1224416C CN1224416C (en) | 2005-10-26 |
Family
ID=34351143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410013873 Expired - Fee Related CN1224416C (en) | 2004-01-07 | 2004-01-07 | Chinese medicine for treating keloid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1224416C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953995A (en) * | 2010-08-09 | 2011-01-26 | 冉德学 | Keloid shrinking ointment |
CN102512618A (en) * | 2012-01-10 | 2012-06-27 | 隋玉兰 | Medicament for treating cicatrices |
CN104547758A (en) * | 2015-02-03 | 2015-04-29 | 王竞鹏 | Medicine for treating qi-deficiency and blood-stasis type keloid and preparation method thereof |
CN107582976A (en) * | 2017-10-16 | 2018-01-16 | 彭金鹏 | A kind of Chinese medicine composition and preparation method for repairing striae of pregnancy |
-
2004
- 2004-01-07 CN CN 200410013873 patent/CN1224416C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101953995A (en) * | 2010-08-09 | 2011-01-26 | 冉德学 | Keloid shrinking ointment |
CN101953995B (en) * | 2010-08-09 | 2011-11-16 | 冉德学 | Keloid shrinking ointment |
CN102512618A (en) * | 2012-01-10 | 2012-06-27 | 隋玉兰 | Medicament for treating cicatrices |
CN102512618B (en) * | 2012-01-10 | 2013-03-27 | 隋玉兰 | Medicament for treating cicatrices |
CN104547758A (en) * | 2015-02-03 | 2015-04-29 | 王竞鹏 | Medicine for treating qi-deficiency and blood-stasis type keloid and preparation method thereof |
CN107582976A (en) * | 2017-10-16 | 2018-01-16 | 彭金鹏 | A kind of Chinese medicine composition and preparation method for repairing striae of pregnancy |
Also Published As
Publication number | Publication date |
---|---|
CN1224416C (en) | 2005-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101485865B (en) | Chinese medicine fat-reducing plaster | |
CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
CN101130023A (en) | Stomach warming codonopsis powder | |
CN100396321C (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
CN101239134B (en) | Speckle-removing medicinal composition | |
CN1224416C (en) | Chinese medicine for treating keloid | |
CN102895610A (en) | Medicine for treating edema | |
CN101569711A (en) | Medicament for treating acne rosacea and preparation method thereof | |
CN108272986A (en) | A kind of draft is bathed powder | |
CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
CN102805825B (en) | Drug for curing cutaneous pruritus and preparation method thereof | |
CN102671180B (en) | Medicine for treating rheumatic lumbago and preparation method thereof | |
CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
CN109464640A (en) | Conditioning alopecia is lived again the edible medicine and preparation method thereof of blackening hair | |
CN108653572A (en) | A kind of extract oral agent that treating constipation and preparation method | |
CN102600388B (en) | Traditional Chinese herbal medicine for treating threatened abortion of livestock | |
CN102935191B (en) | Medicine for ischialgia and method for preparing medicine for ischialgia | |
CN106421534A (en) | Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof | |
CN106310082A (en) | Kidney-tonifying traditional Chinese medicine composition and preparation method thereof | |
CN1059588C (en) | Method for strengthening yang | |
CN1171967A (en) | Medicinal liquid Yuyepizhengke for curing rheumatic arthritis | |
CN104491351A (en) | Drug for treating haemorrhoids and preparation method of drug | |
CN103656531A (en) | Traditional Chinese medicine for treating urticaria | |
CN103330896A (en) | Preparation method of powder for treating postpartum nonspecific vaginitis | |
CN111558027A (en) | Fumigating traditional Chinese medicine composition for postpartum rehabilitation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |